Literature DB >> 8108371

Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy.

R Bittner1, M Butters, M Büchler, S Nägele, R Roscher, H G Beger.   

Abstract

In a prospective clinical-experimental study, 15 consecutive patients with chronic pancreatitis, operated on because of severe pain, were examined for the effects of a duodenum-preserving resection of the pancreas head on endocrine pancreas function. This was done by means of oral and intravenous glucose tolerance testing before the operation, on the 10th or 11th day postoperatively, and 3 months after the operation. In addition to glucose levels in the peripheral venous blood, levels of insulin, C-peptide, glucagon, and pancreatic polypeptide were determined. As indicated by the k value, glucose tolerance improved postoperatively in 10 patients (66.6%); three patients (19.9%) showed no change, and one patient (6.6%) was worse. Only one patient (6.6%) developed evident diabetes mellitus immediately postoperatively. Pre- and postoperative levels of insulin and C-peptide showed no significant differences. The fasting levels of glucagon were significantly lower postoperatively than before the operation (p < 0.01). The stimulation of pancreatic polypeptide after oral glucose was significantly lower postoperatively (p < 0.01). Duodenum-preserving pancreas head resection does not lead to an impairment of glucose tolerance in the majority of patients; a deterioration was observed only in few cases (13.3%).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108371     DOI: 10.1097/00006676-199401000-00007

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

1.  The Beger procedure--duodenum-preserving pancreatic head resection.

Authors:  Hans G Beger; Rainer Kunz; Bertram Poch
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

Review 2.  Clinical uses of gut peptides.

Authors:  J Geoghegan; T N Pappas
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

Review 3.  [Duodenum-preserving pancreatic head resection in chronic pancreatitis : Limitations of the Heidelberg multicenter ChroPac study].

Authors:  H G Beger; B Mayer
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

Review 4.  Diabetes after pancreatic surgery: novel issues.

Authors:  Marina Scavini; Erica Dugnani; Valentina Pasquale; Daniela Liberati; Francesca Aleotti; Gaetano Di Terlizzi; Giovanna Petrella; Gianpaolo Balzano; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

5.  Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience.

Authors:  H G Beger; W Schlosser; H M Friess; M W Büchler
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

6.  Surgical treatment of chronic pancreatitis with pancreatic main duct dilatation: long term results after head resection and duct drainage.

Authors:  W Schlosser; A Schwarz; H G Beger
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

7.  Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head.

Authors:  H G Beger; M Büchler
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

8.  [Effect of resection or duct drainage on glucose stimulated beta cell function in chronic pancreatitis].

Authors:  J W Heise; H Becker; C Niederau; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1994

9.  Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.

Authors:  E H Eddes; M Verkijk; H A Gielkens; I Biemond; W Bemelman; C B Lamers; A A Masclee
Journal:  Int J Pancreatol       Date:  2001

10.  Clinical efficacy of organ-preserving pancreatectomy for benign or low-grade malignant potential lesion.

Authors:  Seung Eun Lee; Jin-Young Jang; Dae Wook Hwang; Kuhn Uk Lee; Sun-Whe Kim
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.